[1]崔茜 裴汉军.主动脉内球囊反搏治疗急性ST段抬高心肌梗死合并心源性休克的研究进展[J].心血管病学进展,2021,(7):597-600.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.006]
　CUI Qian,PEI Hanjun.Treatment of Acute ST Segment Elevation Myocardial Infarction Complicated with Cardiogenic Shock by Intra-aortic Balloon Counterpulsation[J].Advances in Cardiovascular Diseases,2021,(7):597-600.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.006]
点击复制

主动脉内球囊反搏治疗急性ST段抬高心肌梗死合并心源性休克的研究进展()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2021年7期
页码:
597-600
栏目:
出版日期:
2021-07-25

文章信息/Info

Title:
Treatment of Acute ST Segment Elevation Myocardial Infarction Complicated with Cardiogenic Shock by Intra-aortic Balloon Counterpulsation
作者:
崔茜 裴汉军
(内蒙古科技大学包头医学院第一附属医院心内科,内蒙古 包头 014010 )
Author(s):
CUI Qian; PEI Hanjun
(Department of Cardiology,The First Affiliated Hospital of Baotou Medical College,Inner Mongolia University of Science and Technology,Baotou 014010,Neimenggu,China)
关键词:
主动脉内球囊反搏; ST段抬高心肌梗死; 心源性休克
Keywords:
Intra-aortic balloon counterpulsation; ST segment elevation myocardial infarction; Cardiogenic shock
DOI:
10.16806/j.cnki.issn.1004-3934.2021.07.006
摘要:
】急性ST段抬高心肌梗死合并心源性休克是心内科常见急危重症。主动脉内球囊反搏可增加冠状动脉血流量和改善全身灌注，降低心脏后负荷，是治疗急性心肌梗死合并心源性休克常用的机械辅助装置，但目前主动脉内球囊反搏的临床应用仍存在争议。现对主动脉内球囊反搏的最新研究进展进行综述。
Abstract:
Acute ST Segment elevation myocardial infarction complicated with cardiogenic shock is a common critical disease in cardiology. Intra-aortic balloon counterpulsation(IABP) can increase coronary blood flow,improve systemic perfusion,and reduce cardiac afterload. It is a commonly used mechanical auxiliary device in the treatment of acute myocardial infarction complicated with cardiogenic shock. However,the clinical application of IABP is still controversial. This article reviews the latest research progress of IABP

参考文献/References:

[1]Kastrati A,Colleran R,Ndrepepa G. Cardiogenic shock:how long does the storm last?[J]. J Am Coll Cardiol,2016,67(7):748-750.

[2]Thiele H,Zeymer U,Neumann FJ,et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock[J]. N Engl J Med,2012,367(14):1287-1296.

[3]Neumann FJ,Sousa-Uva M,Ahlsson A,et al. 2018 ESC/EACTS Guidelines on myocardial revascularization[J]. Eur Heart J,2019,40(2):87-165.

[4]Sanborn TA,Sleeper LA,Bates ER,et al. Impact of thrombolysis,intra-aortic balloon pump counterpulsation,and their combination in cardiogenic shock complicating acute myocardial infarction:a report from the SHOCK Trial Registry.Should we emergently revascularize Occluded Coronaries for cardiogenic shocK?[J]. J Am Coll Cardiol,2000,36(3 suppl A):1123-1129.

[5]Thiele H,Zeymer U,Neumann FJ,et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK Ⅱ):final 12 month results of a randomised,open-label trial[J]. Lancet,2013,382(9905):1638-1645.

[6]Thiele H,Zeymer U,Thelemann N,et al. Intraaortic balloon pump in cardiogenicshock complicating acute myocardial infarction:long-term 6-year outcome of the randomized IABP-SHOCK Ⅱ trial[J]. Circulation,2018,22(8):2405-2414.

[7]Sandhu A,McCoy LA,Negi SI,et al. Use of mechanical circulatory support in patients undergoing percutaneous coronary intervention:insights from the National Cardiovascular Data Registry[J]. Circulation,2015,132(13):1243-1251.

[8]Backhaus T,Fach A,Schmucker J,et al. Management and predictors of outcome in unselected patients with cardiogenic shock complicating acute ST-segment elevation myocardial infarction:results from the Bremen STEMI Registry[J]. Clin Res Cardiol,2018,107(5):371-379.

[9]Mao CT,Wang JL,Chen DY,et al. Benefits of intraaortic balloon support for myocardial infarction patients in severe cardiogenic shock undergoing coronary revascularization[J]. PLoS One,2016,11(8):e0160070.

[10]Schwarz B,Abdel-Wahab M,Robinson DR,et al. Predictors of mortality in patients with cardiogenic shock treated with primary percutaneous coronary intervention and intra-aortic balloon counterpulsation[J]. Med Klin Intensivmed Notfmed, 2016,111(8):715-722.

[11]Kohl LP,Leimberger JD,Chiswell K,et al. Clinical characteristics and outcomes after unplanned intraaortic balloon counterpulsation in the Counterpulsation to Reduce Infarct Size Pre-PCI Acute Myocardial Infarction trial[J]. Am Heart J,2016,174:7-13.

[12]Patel MR,Smalling RW,Thiele H,et al. Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial[J]. JAMA,2011,306(12):1329-1337.

[13]van Nunen LX,van’t Veer M,Schampaert S,et al. Intra-aortic balloon counterpulsation reduces mortality in large anterior myocardial infarction complicated by persistent ischaemia:a CRISP-AMI substudy[J]. EuroIntervention,2015,11(3):286-292.

[14]van Nunen LX,van’t Veer M,Zimmermann FM,et al. Intra-aortic balloon pump counterpulsation in extensive myocardial infarction with persistent ischemia:The SEMPER FI pilot study[J]．Catheter Cardiovasc Interv,2020,95(1):128-135.

[15]Perera D,Stables R,Thomas M,et al. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention:a randomized controlled trial[J]. JAMA,2010,304(8):867-874.

[16]Yuan L,Nie SP. Efficacy of intra-aortic balloon pump before versus after primary percutaneous coronary intervention in patients with cardiogenic shock from ST-elevation myocardial infarction[J]. Chin Med J (Engl),2016,129(12):1400-1405.

[17]Zehetgruber M,Mundigler G,Christ G,et al. Relation of hemodynamic variables to augmentation of left anterior descending coronary flow by intraaortic balloon pulsation in coronary artery disease[J]. Am J Cardiol,1997,80(7):951-955.

[18]Kimura A,Toyota E,Lu S,et al. Effects of intraaortic balloon pumping on septal arterial blood flow velocity waveform during severe left main coronary artery stenosis[J]. J Am Coll Cardiol,1996,27(4):810-816.

[19]Deppe AC,Weber C,Liakopoulos OJ,et al. Preoperative intra-aortic balloon pump use in high-risk patients prior to coronary artery bypass graft surgery decreases the risk for morbidity and mortality—A meta-analysis of 9,212 patients[J]. J Card Surg,2017,32(3):177-185.

[20]Ouweneel DM,Eriksen E,Sjauw KD,et al. Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction[J]. J Am Coll Cardiol,2017,69(3):278-287.

[21]Dhruva SS,Ross JS,Mortazavi BJ,et al. Association of use of an intravascular microaxial left ventricular assist device vs intra-aortic balloon pump with in-hospital mortality and major bleeding among patients with acute myocardial infarction complicated by cardiogenic shock[J]. JAMA,2020,323(8):734-745.

[22]O’Neill WW,Kleiman NS,Moses J,et al. A prospective,randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention:the PROTECT Ⅱ study[J]. Circulation,2012,126(14):1717-1727.

[23]Thiele H,Sick P,Boudriot E,et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock[J]. Eur Heart J,2005,26(13):1276-1283.

[24]Truby LK,Takeda K,Mauro C,et al. Incidence and implications of left ventricular distention during venoarterial extracorporeal membrane oxygenation support[J]. ASAIO J,2017,63(3):257-265.

[25]Makdisi G,Wang IW. Extra Corporeal Membrane Oxygenation(ECMO) review of a lifesaving technology[J]. J Thorac Dis,2015,7(7):E166-E176.

[26]Meani P,Gelsomino S,Natour E,et al. Modalities and effects of left ventricle unloading on extracorporeal life support:a review of the current literature[J]. Eur J Heart Fail,2017,19 suppl 2:84-91.

[27]Petroni T,Harrois A,Amour J,et al. Intra-aortic balloon pump effects on macrocirculation and microcirculation in cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation[J]. Crit Care Med,2014,42(9):2075-2082.

[28]侯剑峰,陈凯,唐汉韡,等. 体外膜肺氧合与主动脉球囊反搏联合辅助救治心血管外科术后心源性休克：阜外医院单中心十一年经验总结[J]. 中国循环杂志,2019,34(1):66-71.

[29]Lin LY,Liao CW,Wang CH,et al. Effects of additional intra-aortic balloon counter-pulsation therapy to cardiogenic shock patients supported by extra-corporeal membranous oxygenation[J]. Sci Rep,2016,6:23838.

[30]Koudoumas D,Malliaras K,Theodoropoulos S,et al. Long-term intra-aortic balloon pump support as bridge to left ventricular assist device implantation[J]. J Card Surg,2016,31(7):467-471.

[31]den Uil CA,Galli G,Jewbali LS,et al. First-line support by intra-aortic balloon pump in non-ischaemic cardiogenic shock in the era of modern ventricular assist devices[J]. Cardiology,2017,138(1):1-8.

相似文献/References:

[1]陈佳仑 李树仁.不同策略血栓抽吸对于急性ST段抬高心肌梗死患者的研究进展[J].心血管病学进展,2021,(7):593.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.005]
　CHEN Jialun,LI Shuren.Different Strategies of Thrombus Aspiration in Patients with Acute ST Elevation Myocardial Infarction[J].Advances in Cardiovascular Diseases,2021,(7):593.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.005]
[2]夏平.“8+2”心电图临床价值的研究进展夏平[J].心血管病学进展,2021,(9):800.[doi:【DOI】10.16806/j.cnki.issn.1004-3934.2021.09.009]
　XIA Ping.Clinical Value of 8 Plus 2 ECG[J].Advances in Cardiovascular Diseases,2021,(7):800.[doi:【DOI】10.16806/j.cnki.issn.1004-3934.2021.09.009]
[3]谭莹 毛雅晶 马楠 鲍雪 康丽娜 徐标.中性粒细胞与淋巴细胞比值对STEMI再灌注损伤后微血管阻塞的预测价值[J].心血管病学进展,2023,(1):87.[doi:10.16806/j.cnki.issn.1004-3934.2023.01.019]
　TAN YingMAO Yajing MA NanBAO XueKANG LinaXU Biao.Predictive Value of Neutrophil-to-Lymphocyte Ratio for MVO After STEMI Reperfusion Injury[J].Advances in Cardiovascular Diseases,2023,(7):87.[doi:10.16806/j.cnki.issn.1004-3934.2023.01.019]
[4]程爱媛 苏涛 朱存军 贺媛 张强 刘卫强 林琦 王欢.主动脉内球囊反搏患者拔除后使用Angio-Seal血管闭合装置与人工压迫的止血效果及并发症的比较[J].心血管病学进展,2023,(11):1053.[doi:10.16806/j.cnki.issn.1004-3934.2023.11.021]
　CHENG Aiyuan,SU Tao,ZHU Cunjun,et al.Comparison of Hemostatic Effect and Complications Between the Angio-Seal Vascular Close Device and Routine Arterial Compression in Patients After Removing Intra-Aortic Balloon Pump[J].Advances in Cardiovascular Diseases,2023,(7):1053.[doi:10.16806/j.cnki.issn.1004-3934.2023.11.021]

更新日期/Last Update: 2021-09-10